Increasing pulmonary artery visibility and diagnostic confidence with ultra-high resolution photon-counting detector CT pulmonary angiography - Report - MDSpire

Increasing pulmonary artery visibility and diagnostic confidence with ultra-high resolution photon-counting detector CT pulmonary angiography

  • By

  • Pauline Pannenbecker

  • Camilla Rüth

  • Jan-Peter Grunz

  • Alena Kollmann

  • Philipp Gruschwitz

  • Julius Frederik Heidenreich

  • Andreas Steven Kunz

  • Thorsten Alexander Bley

  • Henner Huflage

  • May 4, 2026

  • 0 min

Share

Clinical Report: Enhancing Visualization of Pulmonary Arteries with PCD-CTPA

Overview

This study evaluates the diagnostic benefits of ultra-high resolution photon-counting detector CT pulmonary angiography (UHR-PCD-CTPA) compared to dual-energy energy-integrating detector CT (EID-CTPA). Findings indicate that UHR-PCD-CTPA provides superior image quality and diagnostic accuracy while reducing radiation exposure and contrast medium use.

Background

CT pulmonary angiography (CTPA) is the gold standard for diagnosing acute pulmonary embolism (PE). Recent advancements in imaging technology, particularly photon-counting detector (PCD) systems, promise enhanced image quality and reduced radiation doses. Understanding the efficacy of UHR-PCD-CTPA is crucial for optimizing diagnostic protocols in clinical practice.

Data Highlights

ParameterUHR-PCD-CTPAEID-CTPA
Image Quality Index (IQ)50, 25Standard
Radiation DoseReducedHigher
Contrast Medium Volume40 mL50 mL

Key Findings

  • UHR-PCD-CTPA demonstrated higher spatial resolution compared to EID-CTPA.
  • Image quality assessments indicated improved contrast-to-noise ratios (CNR) with UHR-PCD-CTPA.
  • UHR-PCD-CTPA allowed for significant reductions in radiation dose and contrast medium usage.
  • Patients undergoing UHR-PCD-CTPA had fewer non-diagnostic studies compared to those with EID-CTPA.
  • The study included 283 adult patients, with a balanced distribution between UHR-PCD-CTPA and EID-CTPA groups.

Clinical Implications

The findings support the integration of UHR-PCD-CTPA in routine clinical practice for diagnosing pulmonary embolism, particularly due to its enhanced image quality and reduced radiation exposure. Clinicians should consider adopting this technology to improve diagnostic accuracy and patient safety.

Conclusion

UHR-PCD-CTPA represents a significant advancement in imaging technology, offering improved diagnostic capabilities for pulmonary embolism while minimizing patient risk. Further studies are warranted to validate these findings across diverse clinical settings.

References

  1. European Radiology, 2025 -- High-Resolution Photon-Counting Detector CT Findings of Lung Microvasculopathy in Patients with Chronic Thromboembolic Pulmonary Hypertension: A Study of 29 Cases
  2. European Radiology, 2025 -- Radiological and Histological Correlation Based on Morphology in Ultra-High-Resolution Energy-Integrating Detector CT of Cadaveric Human Lungs: Analysis of Nodules and Airways
  3. European Radiology, 2023 -- Utilizing Photon-Counting CT for Acute Pulmonary Embolism Diagnosis: Opportunities for Reducing Contrast Agent Use and Radiation Exposure
  4. American College of Cardiology, 2026 -- First AHA/ACC acute pulmonary embolism guideline: prompt diagnosis and treatment are key
  5. European Radiology (Springer) — Photon-counting CT vs V/Q SPECT for lobar perfusion quantification in chronic thromboembolic pulmonary hypertension
  6. The Best of Both Worlds: Ultra-high-pitch Pulmonary Angiography with Free-Breathing Technique by Means of Photon-Counting Detector CT for Diagnosis of Acute Pulmonary Embolism
  7. Comparative accuracy of photon-counting and dual energy CT pulmonary angiography perfusion mapping using V/Q scans as reference standard
  8. First AHA/ACC acute pulmonary embolism guideline: prompt diagnosis and treatment are key - American College of Cardiology

Original Source(s)

Related Content